Skip to main content

Advanced Search

Haematologica
  • Home
  • Current Issue
  • Ahead Of Print
  • Archive
  • Submit a Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Submit a Manuscript
    • Track a Manuscript
  • About Us
    • About Haematologica
    • Editorial Board
    • Our Policies
  • More
    • Advertising
    • Rights & Permissions
    • Alerts
    • Feedback
    • Contact
Lack of mutations in the human telomerase RNA component (hTERC) gene in Fanconi's anemia
RT Calado, MC Pintao, V Rocha, RP Falcao, MA Bitencourt, WA Silva, E Gluckman, R Pasquini, MA Zago
Haematologica January 2004 89: 1012-1013; doi:
RT Calado
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MC Pintao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
V Rocha
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RP Falcao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MA Bitencourt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WA Silva
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E Gluckman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R Pasquini
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MA Zago
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

Author Affiliations

  1. RT Calado,
  2. MC Pintao,
  3. V Rocha,
  4. RP Falcao,
  5. MA Bitencourt,
  6. WA Silva Jr,
  7. E Gluckman,
  8. R Pasquini and
  9. MA Zago
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

As some patients with Fanconi s anemia (FA) present excessive telomere shortening correlating with poor outcome, we investigated whether human telomerase RNA component (hTERC) mutations also play a role in telomere shortening in 115 FA patients. Only one patient was heterozygous for the G58A polymorphism. No other mutation or deletion was found. We conclude that hTERC gene mutations do not contribute to telomere shortening in FA.

PreviousNext
Back to top

Vol 89 Issue 8

Haematologica: 89 (8)
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Email

Thank you for your interest in spreading the word about Haematologica.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Lack of mutations in the human telomerase RNA component (hTERC) gene in Fanconi's anemia
(Your Name) has forwarded a page to you from Haematologica
(Your Name) thought you would like to see this page from the Haematologica web site.
Citation Tools
Lack of mutations in the human telomerase RNA component (hTERC) gene in Fanconi's anemia
RT Calado, MC Pintao, V Rocha, RP Falcao, MA Bitencourt, WA Silva, E Gluckman, R Pasquini, MA Zago
Haematologica Jan 2004, 89 (8) 1012-1013;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
RT Calado, MC Pintao, V Rocha, RP Falcao, MA Bitencourt, WA Silva, E Gluckman, R Pasquini, MA Zago
Haematologica Jan 2004, 89 (8) 1012-1013;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Alert me when this article is cited
  • Alert me if a correction is posted

Jump To

  • Article
  • Info & Metrics
  • PDF

More in this TOC Section

  • Vitamin D receptor gene polymorphisms and risk of non-Hodgkin’s lymphoma
  • Rituximab and dose dense chemotherapy in primary breast lymphoma
  • Bayesian detection of abnormal hematological values to introduce a no-start rule for heterogeneous populations of athletes
Show more Letter

Related Articles

Cited By...

What about you?
Tell us your interests and get all the new contents of Haematologica in advance

 

 

Navigate

  • Home
  • Current issue
  • Ahead of print
  • Archive
  • Info for
    • Authors
    • Reviewers
    • Advertisers
    • Subscribers
  • About us
    • About Haematologica
    • Editorial Board
    • Our policies

For Authors

  • Author guidelines
  • Submit Manuscript
  • Track Manuscript

For Reviewers

  • Reviewer Guidelines
  • Access Your Profile
  • Access Your Tasks
  • 2014 reviewers

For Advertisers

  • Information For Advertising

Education

  • Review Articles
  • Guideline Articles

More

  • Rights & Permissions
  • Advertising
  • Alerts
  • Feedback
  • Contact
  • App

Copyright © 2019 by the Ferrata Storti Foundation

ISSN 0390-6078 print

ISSN 1592-8721 online